The existence of interactive effects of a dichotomous treatment variable on the relationship between the continuous predictor and response variables is an essential issue in biological and medical sciences. Also, considerable attention has been devoted to raising awareness of the often-untenable assumption of homogeneous error variance among treatment groups. Although the procedures for detecting interactions between treatment and predictor variables are well documented in the literature, the corresponding problem of power and sample size calculations has received relatively little attention. In order to facilitate interaction design planning, this article describes power and sample size procedures for the extended Welch test of difference ...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
The existence of interactive effects of a dichotomous treatment variable on the relationship between...
ABSTRACT: This article presents methods for sample size and power calculations for studies involving...
Pharmacogenetic trials investigate the effect of genotype on treatment response. When there are two ...
Pharmacogenetic trials investigate the effect of genotype on treatment response. When there are two ...
Pharmacogenetic trials investigate the effect of genotype on treatment response. When there are two ...
The appraisals of treatment-covariate interaction have theoretical and substantial implications in a...
Patient-reported outcomes (PRO) that comprise all self-reported measures by the patient are importan...
Background: Patient-reported outcomes (PRO) that comprise all self-reported measures by the patient ...
This article presents a general set of procedures for comparing the effect sizes of two or more inde...
BACKGROUND: Patient-reported outcomes (PRO) that comprise all self-reported measures by the patient ...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
The existence of interactive effects of a dichotomous treatment variable on the relationship between...
ABSTRACT: This article presents methods for sample size and power calculations for studies involving...
Pharmacogenetic trials investigate the effect of genotype on treatment response. When there are two ...
Pharmacogenetic trials investigate the effect of genotype on treatment response. When there are two ...
Pharmacogenetic trials investigate the effect of genotype on treatment response. When there are two ...
The appraisals of treatment-covariate interaction have theoretical and substantial implications in a...
Patient-reported outcomes (PRO) that comprise all self-reported measures by the patient are importan...
Background: Patient-reported outcomes (PRO) that comprise all self-reported measures by the patient ...
This article presents a general set of procedures for comparing the effect sizes of two or more inde...
BACKGROUND: Patient-reported outcomes (PRO) that comprise all self-reported measures by the patient ...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...
International audienceBackground: Patient-reported outcomes (PRO) are important as endpoints in clin...